beigene.com (BGNE): Operatsion rentabellik

Ommaviy kompaniya BeiGene Ltd (BGNE) logotipi

Xitoy va New Jersey’dagi zamonaviy zavodlar BeiGene, Ltd. (BGNE) barqarorligini ta'minlaydi. Ushbu operatsion marja grafigi xarajatlarni boshqarish samaradorligini vizuallashtiradi, bunda 17.80 joriy metrika darajasini ifodalaydi. Yangi dori vositalarining muvaffaqiyatli sinovlari kompaniyaga dempingga murojaat qilmasdan bozor ulushini egallash imkonini beradi. Biroq, AQSh va Xitoy o'rtasidagi savdo urushlari biznesni G'arb investitsiyalari va sotuvlaridan ayirib qo'yish xavflarini yuzaga keltirmoqda.

BGNE: BeiGene Ltd. Sotuvning operatsion rentabelligi 04.07.2022 - 20.11.2026

BeiGene (BGNE) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Fundamental baholash:BeiGene, Ltd., BGNE
beigene.com asosiy tovari

BeiGene, Ltd. (BGNE) kompaniyasining onkologiya sektoridagi kengayishi va noyob dori vositalari hisobiga erishgan ustunligi kompaniyaga dumpingdan qochish imkonini beradi, bu esa uning biznes modelining samaradorligiga bevosita ta'sir qiladi. Operatsion rentabellik tahlili soliqlar va foizlar to'lanishidan oldin operatsion xarajatlar qoplanib qolgan daromad qismini aks ettiradi, bu esa aktivning foyda keltirish bo'yicha fundamental qobiliyatini xarakterlaydi va uning investitsiya darajasini belgilaydi.

Raqobatdosh kompaniyalar

Operatsion rentabellik BeiGene Ltd|Halozyme Therapeutics - Operatsion foyda marjasi|Sotuvning operatsion marjasi RVMD (Revolution Medicines Corp)|Operatsion foyda koeffitsiyenti AAPG|Operatsion rentabellik CG Oncology Therapeutics CGON|Operatsion foyda normasi URGN|BCAX: Sotuvning operatsion marjasi|PSNL: Operatsion rentabellik|Erasca (ERAS) - Operatsion rentabellik|DCTH - Operatsion faoliyat rentabelligi|YMAB (Y-mAbs Corp) - Operatsion marja|Sotuvning operatsion marjasi Aura Biosciences (AURA)|Operatsion rentabellik Candel Therapeutics Inc. (CADL)|Sotuvning operatsion marjasi Accuray, Inc. ARAY|Operatsion rentabellik sellaslifesciences.com SLS|Operatsion foyda normasi ACTU|CTOR - Operatsion rentabellik|Operatsion faoliyat rentabelligi tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Operatsion rentabellik|FATE: Operatsion foyda koeffitsiyenti|WHWK (Aadi Bioscience, Inc.) - Operatsion marja|TCRX (TScan Therapeutics) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Champions Oncology (CSBR)|Operatsion faoliyat rentabelligi XBiotech USA|Operatsion rentabellik CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Sotuvning operatsion rentabelligi|RADX - Operatsion rentabellik|ARTV - Operatsion marja|Adlai Nortye Ltd (ANL) - Operatsion rentabellik|Veru Pharma - Operatsion foyda normasi|Operatsion rentabellik Tempest Therapeutics Corp|Operatsion foyda bo'yicha sotuv rentabelligi XLO (Xilio Therapeutics, Inc.)|Operatsion marja RENB|MURA (Mural Oncology) - Operatsion foyda normasi|Operatsion marja KAPA (Kairos Pharma Ltd)|OKUR: Operatsion foyda bo'yicha sotuv rentabelligi|GDTC: Sotuvning operatsion marjasi|CRIS - Operatsion marja|APLM: Operatsion marja|Sotuvning operatsion rentabelligi tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Operatsion marja|Operatsion marja Genprex Inc.|Operatsion marja CLDI|Sotuvning operatsion marjasi Sunshine Biopharma, Inc. SBFM|Operatsion marja XBIO (Xenetic Biosciences)|Operatsion foyda normasi SLRX|PPBT - Operatsion rentabellik|AONC (aoncology.com) - Operatsion foyda bo'yicha sotuv rentabelligi|CKPT: Operatsion marja|Elevation Oncology - Operatsion foyda normasi|ICAD (iCAD) - Operatsion marja|IKNA: Operatsion foyda normasi|Operatsion rentabellik Notable Labs (NTBL)|VIRX (Viracta Therapeutics, Inc.) - Operatsion foyda normasi|Operatsion rentabellik MorphoSys Corporation MOR|NAYA: Operatsion foyda bo'yicha sotuv rentabelligi|Ascentage Pharma Group International - Operatsion marja